{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T11:58:09Z","timestamp":1786967889980,"version":"build-2736575974"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["F\/050011\/02\/X32"],"award-info":[{"award-number":["F\/050011\/02\/X32"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["2015F3JHMB"],"award-info":[{"award-number":["2015F3JHMB"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["15707"],"award-info":[{"award-number":["15707"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.canlet.2020.05.031","type":"journal-article","created":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T02:05:24Z","timestamp":1591063524000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["The two faces of giant cell tumor of bone"],"prefix":"10.1016","volume":"489","author":[{"given":"Federica","family":"Scotto di Carlo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Whyte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3812-2471","authenticated-orcid":false,"given":"Fernando","family":"Gianfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2020.05.031_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ocl.2005.08.005","article-title":"Giant cell tumor of bone","volume":"37","author":"Turcotte","year":"2006","journal-title":"Orthop. Clin. N. Am."},{"key":"10.1016\/j.canlet.2020.05.031_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1148\/rg.331125089","article-title":"Giant cell tumor of bone: review, mimics, and new developments in treatment","volume":"33","author":"Chakarun","year":"2013","journal-title":"Radiographics"},{"key":"10.1016\/j.canlet.2020.05.031_bib3","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/17453674.2018.1490987","article-title":"Incidence and demographics of giant cell tumor of bone in The Netherlands: first nationwide Pathology Registry Study","volume":"89","author":"Verschoor","year":"2018","journal-title":"Acta Orthop."},{"key":"10.1016\/j.canlet.2020.05.031_bib4","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/jbmr.2349","article-title":"Clinical characteristics and evolution of giant cell tumor occurring in Paget\u2019s disease of bone","volume":"30","author":"Rendina","year":"2015","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib5","doi-asserted-by":"crossref","first-page":"63121","DOI":"10.18632\/oncotarget.18670","article-title":"The distinct clinical features of giant cell tumor of bone in pagetic and non-pagetic patients are associated with genetic, biochemical and histological differences","volume":"8","author":"Divisato","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2020.05.031_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/1097-0142(197005)25:5<1061::AID-CNCR2820250509>3.0.CO;2-E","article-title":"Giant\u2010cell tumor: a study of 195 cases","volume":"25","author":"Dahlin","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2020.05.031_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00003086-200204000-00029","article-title":"Giant cell tumor of long bone: a Canadian Sarcoma Group study","volume":"397","author":"Turcotte","year":"2002","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00256-007-0310-x","article-title":"Giant cell tumor complicating Paget disease of long bone","volume":"36","author":"Hoch","year":"2007","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.canlet.2020.05.031_bib9","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s00264-006-0215-7","article-title":"Giant cell tumour of bone: morphological, biological and histogenetical aspects","volume":"30","author":"Werner","year":"2006","journal-title":"Int. Orthop."},{"key":"10.1016\/j.canlet.2020.05.031_bib10","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1038\/ng.2814","article-title":"Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone","volume":"45","author":"Behjati","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2020.05.031_bib11","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.bone.2012.10.002","article-title":"Giant cell tumor of bone: a basic science perspective","volume":"52","author":"Cowan","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2020.05.031_bib12","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2106\/00004623-198769010-00018","article-title":"Giant-cell tumor of bone","volume":"69","author":"Campanacci","year":"1987","journal-title":"J Bone Joint Surg Am."},{"key":"10.1016\/j.canlet.2020.05.031_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0002-9440(10)62959-8","article-title":"Molecular profiling of giant cell tumor of bone and the osteoclastic localization of ligand for receptor activator of nuclear factor kappaB","volume":"167","author":"Morgan","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2020.05.031_bib14","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1359\/jbmr.2000.15.4.640","article-title":"Expression of osteoclast differentiation signals by stromal elements of giant cell tumors","volume":"15","author":"Atkins","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1245\/s10434-009-0803-z","article-title":"Primary malignant giant-cell tumor of bone has high survival rate","volume":"17","author":"Domovitov","year":"2010","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib16","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.otsr.2009.12.007","article-title":"Fatal lung metastasis secondary to index finger giant cell tumor in an 8-year-old child","volume":"96","author":"Jacopin","year":"2010","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib17","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/410973","article-title":"Giant cell tumors of the axial skeleton","volume":"2012","author":"Balke","year":"2012","journal-title":"Sarcoma"},{"key":"10.1016\/j.canlet.2020.05.031_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/BRS.0b013e3182233ccd","article-title":"Giant cell tumor of the mobile spine: a review of 49 cases","volume":"37","author":"Boriani","year":"2012","journal-title":"Spine"},{"key":"10.1016\/j.canlet.2020.05.031_bib19","series-title":"Neoplasia in Molecular Pathology the Molecular Basis of Human Disease","first-page":"71","author":"Coleman","year":"2018"},{"key":"10.1016\/j.canlet.2020.05.031_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.blo.0000063784.32430.b0","article-title":"Multicentric giant cell tumor of bone: a case report and review of the literature","volume":"410","author":"Taylor","year":"2003","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib21","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1002\/ijc.25205","article-title":"Silencing of the UCHL1 gene in giant cell tumors of bone","volume":"127","author":"Fellenberg","year":"2010","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.canlet.2020.05.031_bib22","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1186\/1752-1947-3-9331","article-title":"Tenosynovial giant cell tumors as accidental findings after episodes of distortion of the ankle: two case reports","volume":"3","author":"Illian","year":"2009","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.canlet.2020.05.031_bib23","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/CCO.0b013e32832c951d","article-title":"Giant cell tumour of bone","volume":"21","author":"Thomas","year":"2009","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1051\/sicotj\/2017041","article-title":"Giant cell tumor of bone revisited","volume":"3","author":"Mavrogenis","year":"2017","journal-title":"SICOT-J."},{"key":"10.1016\/j.canlet.2020.05.031_bib25","article-title":"Malignancy in giant cell tumor of bone: a review of the literature","volume":"18","author":"Palmerini","year":"2019","journal-title":"Technol. Canc. Res. Treat."},{"key":"10.1016\/j.canlet.2020.05.031_bib26","doi-asserted-by":"crossref","DOI":"10.1007\/s00264-005-0061-z","article-title":"Impending fractures in giant cell tumours of the distal femur: incidence and outcome","volume":"30","author":"Jeys","year":"2006","journal-title":"Int. Orthop."},{"key":"10.1016\/j.canlet.2020.05.031_bib27","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jcot.2017.07.007","article-title":"Wide resection versus curettage in giant cell tumor with pathological fracture? A systematic review and meta-analysis","volume":"9","author":"Salunke","year":"2018","journal-title":"J. Clin. Orthop. Trauma."},{"key":"10.1016\/j.canlet.2020.05.031_bib28","series-title":"Tumors and Tumor-like Lesions of Bone: Imaging and Pathology of Specific Lesions in Diagnosis of Bone and Joint Disorders","first-page":"3628","author":"Resnick","year":"1995"},{"key":"10.1016\/j.canlet.2020.05.031_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s11999-010-1501-7","article-title":"Giant cell tumor of bone: risk factors for recurrence","volume":"469","author":"Klenke","year":"2011","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib30","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1016\/j.otsr.2013.07.006","article-title":"French sarcoma and bone tumor study groups GSF-GETO, local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French sarcoma and bone tumor study groups)","volume":"99","author":"Gouin","year":"2013","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bone.2007.08.038","article-title":"Bisphosphonates reduce local recurrence in extremity giant cell tumor of bone: a case-control study","volume":"42","author":"Tse","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.canlet.2020.05.031_bib32","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00402-019-03167-x","article-title":"Denosumab treatment for giant-cell tumor of bone: a systematic review of the literature","volume":"139","author":"Luengo-Alonso","year":"2019","journal-title":"Arch. Orthop. Trauma Surg."},{"key":"10.1016\/j.canlet.2020.05.031_bib33","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1053\/S0046-8177(03)00413-1","article-title":"The origin of the neoplastic stromal cell in giant cell tumor of bone","volume":"34","author":"W\u00fclling","year":"2003","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.canlet.2020.05.031_bib34","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/0973-1482.63552","article-title":"Synchronous multicentric giant cell tumor","volume":"6","author":"Bandyopadhyay","year":"2010","journal-title":"J. Canc. Res. Therapeut."},{"key":"10.1016\/j.canlet.2020.05.031_bib35","first-page":"289","article-title":"Multicentric giant cell tumour of bone","volume":"73","author":"Dhillon","year":"2007","journal-title":"Acta Orthop. Belg."},{"key":"10.1016\/j.canlet.2020.05.031_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/01.blo.0000068770.86536.e1","article-title":"Metachronous multicentric giant cell tumor: a case report and literature review","volume":"412","author":"Haskell","year":"2003","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/1097-0142(19920901)70:5<1124::AID-CNCR2820700517>3.0.CO;2-P","article-title":"Giant cell tumor of the skull","volume":"70","author":"Bertoni","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2020.05.031_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-018-4291-z","article-title":"The identification of H3F3A mutation in giant cell tumour of the clivus and the histological diagnostic algorithm of other clival lesions permit the differential diagnosis in this location","volume":"18","author":"Scotto di Carlo","year":"2018","journal-title":"BMC Canc."},{"key":"10.1016\/j.canlet.2020.05.031_bib39","series-title":"Imaging Bone Tumors Tumor-like Lesions","first-page":"321","article-title":"Giant cell tumor","author":"Kransdorf M","year":"2009"},{"key":"10.1016\/j.canlet.2020.05.031_bib40","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2106\/00004623-198668070-00016","article-title":"Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients","volume":"68","author":"Rock","year":"1986","journal-title":"J. Bone Joint Surg. Am."},{"key":"10.1016\/j.canlet.2020.05.031_bib41","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/cncr.11359","article-title":"Malignancy in giant cell tumor of bone","volume":"97","author":"Bertoni","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2020.05.031_bib42","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3747\/co.v17i4.571","article-title":"Dedifferentiated giant cell tumour of bone in the form of low-grade fibroblastic osteogenic sarcoma: case report of a unique presentation with follow-up","volume":"17","author":"Nahal","year":"2010","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib43","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00132583-200101000-00007","article-title":"How to diagnose malignant giant cell tumor","volume":"6","author":"Unni","year":"2001","journal-title":"Pathol. Case Rev."},{"key":"10.1016\/j.canlet.2020.05.031_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejrad.2010.06.053","article-title":"Late sarcoma development after curettage and bone grafting of benign bone tumors","volume":"77","author":"Picci","year":"2011","journal-title":"Eur. J. Radiol."},{"key":"10.1016\/j.canlet.2020.05.031_bib45","article-title":"Malignant sarcomatous transformation of benign giant cell tumor of bone after treatment with denosumab therapy: a literature review of reported cases","volume":"10","author":"Alaqaili","year":"2018","journal-title":"Cureus"},{"key":"10.1016\/j.canlet.2020.05.031_bib46","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1111\/cge.13247","article-title":"ZNF687 mutations are frequently found in pagetic patients from South Italy: implication in the pathogenesis of Paget's disease of bone","volume":"93","author":"Divisato","year":"2018","journal-title":"Clin. Genet."},{"key":"10.1016\/j.canlet.2020.05.031_bib47","first-page":"424","article-title":"Malignant giant-cell tumor of the parietal bone: case report and review of the literature","volume":"48","author":"Leonard","year":"2001","journal-title":"Neurosurgery"},{"key":"10.1016\/j.canlet.2020.05.031_bib48","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF00357112","article-title":"The role of magnetic resonance imaging in giant cell tumor of bone","volume":"16","author":"Herman","year":"1987","journal-title":"Skeletal Radiol."},{"key":"10.1016\/j.canlet.2020.05.031_bib49","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00003072-199601000-00011","article-title":"The scintigraphic features of giant-cell tumors in relation to other imaging modalities","volume":"21","author":"O'Reilly","year":"1996","journal-title":"Clin. Nucl. Med."},{"key":"10.1016\/j.canlet.2020.05.031_bib50","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s004320100234","article-title":"The nature of giant cell tumor of bone","volume":"127","author":"W\u00fclling","year":"2001","journal-title":"J. Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib51","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/cjp2.13","article-title":"Diagnostic value of H3F3A mutations in giant cell tumour of bone compared to osteoclast-rich mimics","volume":"1","author":"Presneau","year":"2015","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib52","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1097\/PAS.0000000000000512","article-title":"Mutation analysis of H3F3A and H3F3B as a diagnostic tool for giant cell tumor of bone and chondroblastoma","volume":"39","author":"Cleven","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.canlet.2020.05.031_bib53","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/S1097-2765(02)00542-7","article-title":"The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly","volume":"9","author":"Ahmad","year":"2002","journal-title":"Mol. Cell."},{"key":"10.1016\/j.canlet.2020.05.031_bib54","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nsmb.2461","article-title":"Histone chaperones in nucleosome assembly and human disease","volume":"20","author":"Burgess","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.canlet.2020.05.031_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-13887-y","article-title":"The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing","volume":"7","author":"Lim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2020.05.031_bib56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2019.02.001","article-title":"Knock-down of oncohistone H3F3A-G34W counteracts the neoplastic phenotype of giant cell tumor of bone derived stromal cells","volume":"448","author":"Fellenberg","year":"2019","journal-title":"Canc. Lett."},{"key":"10.1016\/j.canlet.2020.05.031_bib57","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1093\/nar\/gkl338","article-title":"The tale beyond the tail: histone core domain modifications and the regulation of chromatin structure","volume":"34","author":"Mersfelder","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib58","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1038\/nsmb851","article-title":"Regulated nucleosome mobility and the histone code","volume":"11","author":"Cosgrove","year":"2004","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.canlet.2020.05.031_bib59","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrm3274","article-title":"Understanding the language of Lys36 methylation at histone H3","volume":"13","author":"Wagner","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.canlet.2020.05.031_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00018-017-2596-8","article-title":"Orchestration of H3K27 methylation: mechanisms and therapeutic implication","volume":"75","author":"Pan","year":"2018","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2020.05.031_bib61","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.jmb.2018.04.014","article-title":"Histone H3.3 G34 mutations alter histone H3K36 and H3K27 methylation in cis","volume":"430","author":"Shi","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.canlet.2020.05.031_bib62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1309\/BPET-F2PE-P2BD-J3P3","article-title":"RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone","volume":"117","author":"Roux","year":"2002","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2020.05.031_bib63","doi-asserted-by":"crossref","DOI":"10.1186\/ar2165","article-title":"Biology of RANK, RANKL, and osteoprotegerin","volume":"9","author":"Boyce","year":"2007","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.canlet.2020.05.031_bib64","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1158\/1078-0432.CCR-12-0578","article-title":"Denosumab induces tumor reduction and bone formation in patients with giant-cell tumor of bone","volume":"18","author":"Branstetter","year":"2012","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib65","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jbo.2015.06.002","article-title":"RANK and RANK ligand expression in primary human osteosarcoma","volume":"4","author":"Branstetter","year":"2015","journal-title":"J. Bone Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib66","first-page":"611","article-title":"Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion","volume":"148","author":"Ueda","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2020.05.031_bib67","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0002-9440(10)63323-8","article-title":"Cathepsin K is the principal protease in giant cell tumor of bone","volume":"165","author":"Lindeman","year":"2004","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2020.05.031_bib68","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/cas.12413","article-title":"Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone","volume":"105","author":"Kaneko","year":"2014","journal-title":"Canc. Sci."},{"key":"10.1016\/j.canlet.2020.05.031_bib69","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ajhg.2015.12.016","article-title":"ZNF687 mutations in severe Paget disease of bone associated with giant cell tumor","volume":"98","author":"Divisato","year":"2016","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.canlet.2020.05.031_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.3993","article-title":"ZNF687 mutations in an extended cohort of neoplastic transformations in Paget\u2019s disease of bone: implication for clinical pathology","author":"Scotto di Carlo","year":"2020","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.canlet.2020.05.031_bib71","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00223-012-9599-0","article-title":"Pathogenesis of Paget disease of bone","volume":"91","author":"Ralston","year":"2012","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.canlet.2020.05.031_bib72","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cell.2011.05.006","article-title":"Analysis of the human endogenous coregulator complexome","volume":"145","author":"Malovannaya","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2020.05.031_bib73","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.celrep.2016.09.037","article-title":"ZMYND8 Co-localizes with NuRD on target genes and regulates poly(ADP-ribose)-dependent recruitment of GATAD2A\/NuRD to sites of DNA damage","volume":"17","author":"Spruijt","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2020.05.031_bib74","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nsmb.2499","article-title":"Acetylation limits 53BP1 association with damaged chromatin to promote homologous recombination","volume":"20","author":"Tang","year":"2013","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.canlet.2020.05.031_bib75","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1101\/gad.252189.114","article-title":"Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination","volume":"29","author":"Gong","year":"2015","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2020.05.031_bib76","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1038\/oncsis.2017.63","article-title":"Overexpression of zinc finger protein 687 enhances tumorigenic capability and promotes recurrence of hepatocellular carcinoma","volume":"6","author":"Zhang","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2020.05.031_bib77","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s00432-008-0370-x","article-title":"Giant cell tumor of bone: treatment and outcome of 214 cases","volume":"134","author":"Balke","year":"2008","journal-title":"J. Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib78","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/CCO.0b013e328354c129","article-title":"RANKL, denosumab, and giant cell tumor of bone","volume":"24","author":"Thomas","year":"2012","journal-title":"Curr. Opin. Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib79","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.canlet.2020.05.031_bib80","doi-asserted-by":"crossref","first-page":"7829","DOI":"10.1073\/pnas.0601643103","article-title":"The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs","volume":"103","author":"Kavanagh","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.canlet.2020.05.031_bib81","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00223-004-0120-2","article-title":"Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone","volume":"75","author":"Cheng","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.canlet.2020.05.031_bib82","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib83","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study","volume":"14","author":"Chawla","year":"2013","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2020.05.031_bib84","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S1470-2045(19)30663-1","article-title":"Denosumab in patients with giant-cell tumour of bone: a multicentre, open-label, phase 2 study","volume":"20","author":"Chawla","year":"2019","journal-title":"Lancet Oncol."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520302937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383520302937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:03:41Z","timestamp":1777550621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383520302937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":84,"alternative-id":["S0304383520302937"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2020.05.031","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The two faces of giant cell tumor of bone","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2020.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}